India · Delayed Price · Currency is INR Bliss GVS Pharma Statistics
Total Valuation
BOM:506197 has a market cap or net worth of INR 54.25 billion. The enterprise value is 52.97 billion.
| Market Cap | 54.25B |
| Enterprise Value | 52.97B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | Jul 8, 2026 |
Share Statistics
BOM:506197 has 106.06 million shares outstanding. The number of shares has increased by 1.47% in one year.
| Current Share Class | 105.79M |
| Shares Outstanding | 106.06M |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 43.64% |
| Owned by Institutions (%) | 8.50% |
| Float | 44.84M |
Valuation Ratios
The trailing PE ratio is 42.63.
| PE Ratio | 42.63 |
| Forward PE | n/a |
| PS Ratio | 5.85 |
| PB Ratio | 4.40 |
| P/TBV Ratio | 4.58 |
| P/FCF Ratio | 66.25 |
| P/OCF Ratio | 39.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.20, with an EV/FCF ratio of 64.69.
| EV / Earnings | 41.02 |
| EV / Sales | 5.71 |
| EV / EBITDA | 32.20 |
| EV / EBIT | 40.41 |
| EV / FCF | 64.69 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.02 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.27 |
| Interest Coverage | 10.92 |
Financial Efficiency
Return on equity (ROE) is 11.60% and return on invested capital (ROIC) is 8.94%.
| Return on Equity (ROE) | 11.60% |
| Return on Assets (ROA) | 5.87% |
| Return on Invested Capital (ROIC) | 8.94% |
| Return on Capital Employed (ROCE) | 10.43% |
| Weighted Average Cost of Capital (WACC) | 10.53% |
| Revenue Per Employee | 8.97M |
| Profits Per Employee | 1.25M |
| Employee Count | 1,033 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 3.24 |
Taxes
In the past 12 months, BOM:506197 has paid 548.62 million in taxes.
| Income Tax | 548.62M |
| Effective Tax Rate | 28.94% |
Stock Price Statistics
The stock price has increased by +213.24% in the last 52 weeks. The beta is 1.13, so BOM:506197's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +213.24% |
| 50-Day Moving Average | 384.72 |
| 200-Day Moving Average | 232.62 |
| Relative Strength Index (RSI) | 64.08 |
| Average Volume (20 Days) | 58,904 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:506197 had revenue of INR 9.27 billion and earned 1.29 billion in profits. Earnings per share was 12.00.
| Revenue | 9.27B |
| Gross Profit | 4.79B |
| Operating Income | 1.31B |
| Pretax Income | 1.90B |
| Net Income | 1.29B |
| EBITDA | 1.58B |
| EBIT | 1.31B |
| Earnings Per Share (EPS) | 12.00 |
Balance Sheet
The company has 1.89 billion in cash and 217.50 million in debt, with a net cash position of 1.67 billion or 15.74 per share.
| Cash & Cash Equivalents | 1.89B |
| Total Debt | 217.50M |
| Net Cash | 1.67B |
| Net Cash Per Share | 15.74 |
| Equity (Book Value) | 12.32B |
| Book Value Per Share | 112.76 |
| Working Capital | 7.11B |
Cash Flow
In the last 12 months, operating cash flow was 1.39 billion and capital expenditures -568.31 million, giving a free cash flow of 818.87 million.
| Operating Cash Flow | 1.39B |
| Capital Expenditures | -568.31M |
| Depreciation & Amortization | 271.99M |
| Net Borrowing | -651.37M |
| Free Cash Flow | 818.87M |
| FCF Per Share | 7.72 |
Margins
Gross margin is 51.70%, with operating and profit margins of 14.14% and 13.93%.
| Gross Margin | 51.70% |
| Operating Margin | 14.14% |
| Pretax Margin | 20.45% |
| Profit Margin | 13.93% |
| EBITDA Margin | 17.07% |
| EBIT Margin | 14.14% |
| FCF Margin | 8.83% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.41%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.41% |
| Dividend Growth (YoY) | 200.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 12.50% |
| Buyback Yield | -1.47% |
| Shareholder Yield | -1.08% |
| Earnings Yield | 2.38% |
| FCF Yield | 1.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 26, 2008. It was a forward split with a ratio of 1.6.
| Last Split Date | Sep 26, 2008 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
BOM:506197 has an Altman Z-Score of 6.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.45 |
| Piotroski F-Score | 6 |